Essilor : Expiration of the Liquidity Contract

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130131:nBw315984a

CHARENTON-LE-PONT, France--(Business Wire)--
Regulatory News :

Essilor (Paris:EI) announces the expiration as of January 24, 2013 of the
liquidity contract signed with CA Cheuvreux. The Company`s liquidity account
included the following cash and Company common shares at this date:

* 0 shares
* € 11,857,851.92

As a reminder, the Company`s liquidity account included the following means at
December 31, 2012:

* 0 shares
* € 11,864,433.09

About Essilor
The world`s leading ophthalmic optics company, Essilor designs, manufactures and
markets a wide range of lenses to improve and protect eyesight. Its corporate
mission is to enable everyone around the world to access lenses that meet his or
her unique vision requirements. To support this mission, the Company allocates
around €150 million to research and development every year, in a commitment to
continuously bring new, more effective products to market. Essilor`s flagship
brands are Varilux®, Crizal®, Definity®, Xperio®, Optifog and Foster Grant®. It
also develops and markets equipment, instruments and services for eyecare
professionals.
Essilor reported consolidated revenue of €4.2 billion in 2011 and employs around
48,700 people in some 100 countries. It operates 19 plants, a total of 390
prescription laboratories and edging facilities, as well as several research and
development centers around the world.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the EuroStoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR FR0000121667;
Reuters: ESSI.PA; Bloomberg: EI:FP.

Essilor
Investor Relations and Financial Communications
Phone: +33 (0)1 49 77 42 16

Copyright Business Wire 2013